A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION
DSpace/Manakin Repository
- DASH Home
- Harvard Law School
- HLS Student Papers
- View Item
A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION
| Title: | A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION |
| Author: | Austin, Susan A. |
| Citation: | A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION (1995 Third Year Paper) |
| Full Text & Related Files: |
saustin.pdf (141.2Kb; PDF) 
saustin.rtf (49.94Kb; RTF file) 
saustin.html (39.37Kb; HTML)
|
| Abstract: | Over the past twenty years, physicians have carried out bone marrow transplants with increasing success. As the procedure gains in acceptance and availability over the coming years, our nation will be faced with important policy choices regarding the regulation of bone marrow transplantation. |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965616 |
This item appears in the following Collection(s)
-
HLS Student Papers [559]
HLS Student Papers
Contact administrator regarding this item (to report mistakes or request changes)
